Javier Crespo

21.4k total citations · 3 hit papers
365 papers, 7.1k citations indexed

About

Javier Crespo is a scholar working on Epidemiology, Hepatology and Surgery. According to data from OpenAlex, Javier Crespo has authored 365 papers receiving a total of 7.1k indexed citations (citations by other indexed papers that have themselves been cited), including 201 papers in Epidemiology, 177 papers in Hepatology and 61 papers in Surgery. Recurrent topics in Javier Crespo's work include Liver Disease Diagnosis and Treatment (151 papers), Hepatitis C virus research (112 papers) and Hepatitis B Virus Studies (67 papers). Javier Crespo is often cited by papers focused on Liver Disease Diagnosis and Treatment (151 papers), Hepatitis C virus research (112 papers) and Hepatitis B Virus Studies (67 papers). Javier Crespo collaborates with scholars based in Spain, United States and Mexico. Javier Crespo's co-authors include F. Pons‐Romero, Amalía Cayón, Emilio Fábrega, Fernando Pons, Gabriel Núñez, Naohiro Inohara, Shoichi Kusumoto, Masahito Hashimoto, Simon J. Foster and Seiichi Inamura and has published in prestigious journals such as Journal of Biological Chemistry, Circulation and SHILAP Revista de lepidopterología.

In The Last Decade

Javier Crespo

326 papers receiving 6.9k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Host Recognition of Bacterial Muramyl Dipeptide Mediated through NOD2

2003 1.3k citations Javier Crespo et al. profile →
Gene expression of tumor necrosis factor α and TNF-receptors, p55 and p75, in nonalcoholic steatohepatitis patients

2001 552 citations Javier Crespo, F. Pons‐Romero et al. Hepatology profile →
Low-to-moderate alcohol consumption is associated with increased fibrosis in individuals with metabolic dysfunction-associated steatotic liver disease

2024 65 citations José Luís Calleja, Paula Iruzubieta et al. profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Javier Crespo	3.7k	2.3k	1.4k	1.3k	932	365	7.1k
Oren Shibolet	2.5k 0.7×	1.4k 0.6×	1.1k 0.7×	865 0.6×	868 0.9×	153	5.6k
Morikazu Onji	4.0k 1.1×	3.6k 1.6×	761 0.5×	1.4k 1.0×	1.1k 1.2×	313	7.3k
Grace L. Su	3.6k 1.0×	2.7k 1.2×	1.5k 1.0×	935 0.7×	1.2k 1.3×	166	8.1k
Yoichi Hiasa	4.2k 1.1×	3.9k 1.7×	765 0.5×	790 0.6×	1.2k 1.2×	406	7.2k
Yves Horsmans	5.3k 1.4×	4.7k 2.1×	1.1k 0.8×	507 0.4×	1.3k 1.3×	238	9.5k
Masanori Abe	3.1k 0.8×	2.4k 1.1×	751 0.5×	1.3k 0.9×	995 1.1×	307	6.3k
Jay H. Lefkowitch	4.9k 1.3×	4.4k 1.9×	1.6k 1.1×	524 0.4×	1.4k 1.5×	141	8.6k
Stephen Ryder	4.3k 1.2×	3.5k 1.5×	1.9k 1.3×	624 0.5×	1.2k 1.3×	199	7.6k
Mario Pirisi	2.8k 0.8×	2.7k 1.2×	680 0.5×	588 0.4×	678 0.7×	308	6.1k
Nobuyuki Enomoto	6.7k 1.8×	6.6k 2.9×	2.1k 1.4×	918 0.7×	1.1k 1.2×	308	11.6k

Countries citing papers authored by Javier Crespo

Since Specialization

Citations

This map shows the geographic impact of Javier Crespo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Javier Crespo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Javier Crespo more than expected).

Fields of papers citing papers by Javier Crespo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Javier Crespo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Javier Crespo. The network helps show where Javier Crespo may publish in the future.

Co-authorship network of co-authors of Javier Crespo

This figure shows the co-authorship network connecting the top 25 collaborators of Javier Crespo. A scholar is included among the top collaborators of Javier Crespo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Javier Crespo. Javier Crespo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ferrer, Consuelo, et al.. (2025). Detection of SARS‐CoV‐2 Virions and RNA in Aerosols From COVID‐19 Environments. Indoor Air. 2025(1).

Tijera, Fátima Higuera-de la, Javier Crespo, Agustı́n Albillos, et al.. (2025). Consenso mexicano sobre abordaje y tratamiento de la hemorragia variceal aguda. Revista de Gastroenterología de México. 90(3). 451–473.

Crespo, Javier, et al.. (2024). Assessing the Therapeutic Potential of Fecal Microbiota Transplantation in Steatotic Liver Disease: Current Insights and Future Pathways. Current Hepatology Reports. 23(4). 435–444. 1 indexed citations

Morano, Luís, Jordi Navarro, Rafael Granados, et al.. (2024). Rate of hepatitis C reinfection after successful direct-acting antivirals treatment among people who inject drugs in Spain: the LIVERate study. BMC Public Health. 24(1). 3167–3167. 1 indexed citations

Cabezas, Joaquín, et al.. (2024). Towards Eradicating Hepatitis C in Spain: Early Insights From the Cantabria Cohort Study. SHILAP Revista de lepidopterología. 3(8). 1129–1131.

Ivancovsky‐Wajcman, Dana, Christopher J. Byrne, John Dillon, et al.. (2024). A narrative review of lifestyle management guidelines for metabolic dysfunction–associated steatotic liver disease. Hepatology. 6 indexed citations

Martín‐Escolano, Rubén, Javier Crespo, Pablo Ryan, et al.. (2023). Immunological and senescence biomarker profiles in patients after spontaneous clearance of hepatitis C virus: gender implications for long-term health risk. Immunity & Ageing. 20(1). 62–62. 4 indexed citations

Iruzubieta, Paula, et al.. (2023). NAFLD and type 2 diabetes: A practical guide for the joint management. Gastroenterología y Hepatología (English Edition). 46(10). 815–825. 1 indexed citations

Santos‐Laso, Álvaro, Joaquín Cabezas, Paula Iruzubieta, et al.. (2023). Fatty Liver Disease, Metabolism and Alcohol Interplay: A Comprehensive Review. International Journal of Molecular Sciences. 24(9). 7791–7791. 15 indexed citations

10.

Santos‐Laso, Álvaro, et al.. (2023). Innovative Therapeutic Approaches in Non-Alcoholic Fatty Liver Disease: When Knowing Your Patient Is Key. International Journal of Molecular Sciences. 24(13). 10718–10718. 9 indexed citations

11.

Cuadrado, Antonio, José Ignacio Fortea, Carlos Rodríguez de Lope, et al.. (2023). Risk of Recurrence of Hepatocarcinoma after Liver Transplantation: Performance of Recurrence Predictive Models in a Cohort of Transplant Patients. Journal of Clinical Medicine. 12(17). 5457–5457. 2 indexed citations

12.

Puente, Ángela, et al.. (2022). Portal Vein Thrombosis in the Setting of Cirrhosis: A Comprehensive Review. Journal of Clinical Medicine. 11(21). 6435–6435. 9 indexed citations

13.

Hermanns, Heike M., Óscar Briz, José M. Herranz, et al.. (2022). Impact of Liver Inflammation on Bile Acid Side Chain Shortening and Amidation. Cells. 11(24). 3983–3983. 5 indexed citations

14.

Iruzubieta, Paula, José Ignacio Fortea, Antonio Cuadrado, et al.. (2021). National digestive disease specialists survey on cardiovascular risk management in non‐alcoholic fatty liver disease in spanish hospitals. Liver International. 41(6). 1243–1253. 5 indexed citations

15.

Arias, M., Joaquín Cabezas, Susana Llerena, et al.. (2021). Successful Direct Acting Antiviral Therapy in Chronic Hepatitis C Normalizes IFNγ and IL2 Production in T Cells Together with TLR8 Expression and Functionality in Peripheral Blood Mononuclear Cells. Viruses. 13(4). 635–635. 2 indexed citations

16.

Santos‐Laso, Álvaro, et al.. (2021). Pathophysiological Mechanisms in Non-Alcoholic Fatty Liver Disease: From Drivers to Targets. Biomedicines. 10(1). 46–46. 18 indexed citations

17.

Crespo, Javier, Raúl J. Andrade, Fernando Alberca de las Parras, et al.. (2020). Resumption of activity in gastroenterology departments. Recommendations by SEPD, AEEH, GETECCU and AEG. Gastroenterología y Hepatología (English Edition). 43(6). 332–347. 9 indexed citations

18.

Arias, M., Paula Iruzubieta, Ángela Puente, et al.. (2016). Increased Expression Profile and Functionality of TLR6 in Peripheral Blood Mononuclear Cells and Hepatocytes of Morbidly Obese Patients with Non-Alcoholic Fatty Liver Disease. International Journal of Molecular Sciences. 17(11). 1878–1878. 28 indexed citations

19.

Romero‐Gómez, Manuel, Ramón Planas, Javier Ampuero, et al.. (2013). Meta‐analysis: pegylated interferon α‐2a achieves higher early virological responses than α‐2b in chronic hepatitis C. Alimentary Pharmacology & Therapeutics. 37(11). 1065–1073. 6 indexed citations

20.

Fábrega, Emilio, J. Figols, Carmen Dueñas, et al.. (1997). Value of endothelin in cellular rejection after liver transplantation. Clinical Transplantation. 11(1). 25–28. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact